Back
Natural Resources Partners LP Vs. Halozyme Therapeutics Industry Stock Comparison
Sell
49
NRP
Natural Resources Partners LP
Last Price:
105.50
Seasonality Move:
6.14%
Sell
35
HALO
Halozyme Therapeutics
Last Price:
42.56
Seasonality Move:
17.03%
Sell
49
Natural Resources Partners LP (NRP)
is a Sell
Is Natural Resources Partners LP a Buy, Sell or Hold?
- The current Natural Resources Partners LP [NRP] share price is $105.50. The Score for NRP is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- NRP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Halozyme Therapeutics (HALO)
is a Sell
Is Halozyme Therapeutics a Buy, Sell or Hold?
- The current Halozyme Therapeutics [HALO] share price is $42.57. The Score for HALO is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NRP Stock Price Chart
What is Natural Resources Partners LP's stock price today?
-
The Natural Resources Partners LP share price today is $105.50
The current trend is moderately bullish and NRP is experiencing slight selling pressure.
HALO Stock Price Chart
What is Halozyme Therapeutics's stock price today?
-
The Halozyme Therapeutics share price today is $42.57
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.
NRP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.85 | Buy |
| Relative Strength Index (14 RSI): | 59.77 | Buy |
| Chaikin Money Flow: | -17145 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (94.72 - 105.04) | Buy |
| Bollinger Bands (100): | (88.41 - 99.97) | Buy |
HALO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.04 | Sell |
| Relative Strength Index (14 RSI): | 26.84 | Sell |
| Chaikin Money Flow: | -3822578 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (48.96 - 58.72) | Sell |
| Bollinger Bands (100): | (51.86 - 60.48) | Sell |
NRP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 106.68 | Sell |
| 20-day SMA: | 100.43 | Buy |
| 50-day SMA: | 97.49 | Buy |
| 200-day SMA: | 92.16 | Buy |
| 8-day EMA: | 105.19 | Buy |
| 20-day EMA: | 102.21 | Buy |
| 50-day EMA: | 98.38 | Buy |
| 200-day EMA: | 90.98 | Buy |
HALO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 55.27 | Sell |
| 20-day SMA: | 54.02 | Sell |
| 50-day SMA: | 55.85 | Sell |
| 200-day SMA: | 48.97 | Sell |
| 8-day EMA: | 52.24 | Sell |
| 20-day EMA: | 54.19 | Sell |
| 50-day EMA: | 55.13 | Sell |
| 200-day EMA: | 50.65 | Sell |
Natural Resources Partners LP Earnings Growth & NRP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Halozyme Therapeutics Earnings Growth & HALO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.
Natural Resources Partners LP Technical Analysis
| Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Halozyme Therapeutics Technical Analysis
| Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||